- Email: [email protected]
Fulfilling the promise of immunology for human health
Clinical Immunology (2009) 133, 155–156
available at www.sciencedirect.com
Clinical Immunology www.elsevier.com/locate/yclim
EDITORIAL
Fulfilling the promise of immunology for human health
As President and President-Elect, we are pleased to provide some exciting updates regarding the Clinical Immunology Society and some changes that will be implemented over the next 12 months. All of this is designed to have the Society fulfill the promise of immunology for human health with particular emphasis on human disease and human immunotherapeutics. Since FOCIS was formed five years ago, CIS has held meetings in conjunction with the FOCIS Annual Meeting. The accompanying photo is from the most recent CIS business meeting in San Francisco, where we tested the powers of resveratrol to prevent aging. To be honest, we haven't seen many positive regenerative effects from this uncontrolled experiment! However, we did find a need to broaden our membership, in order to be sure the CIS serves as the ‘home’ for the next generation of immunotherapists. As importantly, the resveratrol pilot study reinforced to us our
obligation to pass on to the younger among us, the love for clinical immunology and the great promise that immunebased treatments hold for so many of our patients. We renewed our commitment to introduce our young fellows students (through the CIS Schools) and more importantly our young faculty to the art and science of clinical immunology and immunotherapeutics. Thus, after much thoughtful reflection and consideration, the leadership of CIS has decided to hold an independent international Annual Meeting beginning in 2010 in order to foster the promise of immunology for human health with particular emphasis on human disease and human immunotherapeutics. Our new meeting will expand our teaching mission and aspires to focus on junior faculty to whom we owe so much and from whom our patients expect even more.
1521-6616/$ – see front matter © 2009 Elsevier Inc. All rights reserved. doi:10.1016/j.clim.2009.08.011
156 The first meeting will be held in Philadelphia in conjunction with the First North American Primary Immune Deficiency Conference, May 20-23, 2010. The meeting will kick off with qCorporate Thursdayq on May 20th. It will include speakers addressing issues of new human immunotherapeutics where drugs such as infliximab, rituximab, and natalizumab have already dramatically impacted the practice of clinical immunology. The remainder of the meeting will focus on primary immune deficiency diseases, organized by Drs. Charlotte Cunningham-Rundles and Kathleen Sullivan, and includes such renowned immunologists as Jean-Laurent Casanova, Luigi Notarangelo, and Mary Ellen Conley, to name a few. Further details can be found on the CIS web site at http://www.clinimmsoc.org/meetings/2010/piddnc/. We plan to hold an Annual Meeting with alternating areas of focus on primary immune deficiencies, human immunotherapeutics and secondary immunodeficiencies. The leadership of CIS hopes that this international meeting becomes the international home for immune deficiencies and human immunotherapeutics. Clinical Immunology is and will remain the official journal of our Society under the leadership of Drs. Andrew Saxon and George Tsokos. It continues to thrive as one of the premier journals for clinical and translational research. Both Andy and George are working hard to provide the most current
Editorial research and are planning a series of special editions dedicated to specific topics of interest emphasizing interventional immunology in humans. Finally, please watch the CIS web site for changes to the content and look of the site. The Communications Committee, under the direction of Dr. Marc Natter, plans to expand the WEBbook of Biologics Tables (http://biologics.clinimmsoc. org/), current educational opportunities and other resources and references by having the information and activities better linked to Clinical Immunology. The CIS Council is looking forward to these exciting changes and will be calling on our members for assistance and insight as we move forward with implementation. If you have any questions or suggestions about any of the above initiatives, please don't hesitate to contact the National Office at 414.224.8095 or [email protected]. And don't forget to qsave the datesq May 20-23, 2010 for the inaugural CIS meeting in Philadelphia. Sincerely, Carl June, MD President, CIS Steve Holland, MD President-Elect
available at www.sciencedirect.com
Clinical Immunology www.elsevier.com/locate/yclim
EDITORIAL
Fulfilling the promise of immunology for human health
As President and President-Elect, we are pleased to provide some exciting updates regarding the Clinical Immunology Society and some changes that will be implemented over the next 12 months. All of this is designed to have the Society fulfill the promise of immunology for human health with particular emphasis on human disease and human immunotherapeutics. Since FOCIS was formed five years ago, CIS has held meetings in conjunction with the FOCIS Annual Meeting. The accompanying photo is from the most recent CIS business meeting in San Francisco, where we tested the powers of resveratrol to prevent aging. To be honest, we haven't seen many positive regenerative effects from this uncontrolled experiment! However, we did find a need to broaden our membership, in order to be sure the CIS serves as the ‘home’ for the next generation of immunotherapists. As importantly, the resveratrol pilot study reinforced to us our
obligation to pass on to the younger among us, the love for clinical immunology and the great promise that immunebased treatments hold for so many of our patients. We renewed our commitment to introduce our young fellows students (through the CIS Schools) and more importantly our young faculty to the art and science of clinical immunology and immunotherapeutics. Thus, after much thoughtful reflection and consideration, the leadership of CIS has decided to hold an independent international Annual Meeting beginning in 2010 in order to foster the promise of immunology for human health with particular emphasis on human disease and human immunotherapeutics. Our new meeting will expand our teaching mission and aspires to focus on junior faculty to whom we owe so much and from whom our patients expect even more.
1521-6616/$ – see front matter © 2009 Elsevier Inc. All rights reserved. doi:10.1016/j.clim.2009.08.011
156 The first meeting will be held in Philadelphia in conjunction with the First North American Primary Immune Deficiency Conference, May 20-23, 2010. The meeting will kick off with qCorporate Thursdayq on May 20th. It will include speakers addressing issues of new human immunotherapeutics where drugs such as infliximab, rituximab, and natalizumab have already dramatically impacted the practice of clinical immunology. The remainder of the meeting will focus on primary immune deficiency diseases, organized by Drs. Charlotte Cunningham-Rundles and Kathleen Sullivan, and includes such renowned immunologists as Jean-Laurent Casanova, Luigi Notarangelo, and Mary Ellen Conley, to name a few. Further details can be found on the CIS web site at http://www.clinimmsoc.org/meetings/2010/piddnc/. We plan to hold an Annual Meeting with alternating areas of focus on primary immune deficiencies, human immunotherapeutics and secondary immunodeficiencies. The leadership of CIS hopes that this international meeting becomes the international home for immune deficiencies and human immunotherapeutics. Clinical Immunology is and will remain the official journal of our Society under the leadership of Drs. Andrew Saxon and George Tsokos. It continues to thrive as one of the premier journals for clinical and translational research. Both Andy and George are working hard to provide the most current
Editorial research and are planning a series of special editions dedicated to specific topics of interest emphasizing interventional immunology in humans. Finally, please watch the CIS web site for changes to the content and look of the site. The Communications Committee, under the direction of Dr. Marc Natter, plans to expand the WEBbook of Biologics Tables (http://biologics.clinimmsoc. org/), current educational opportunities and other resources and references by having the information and activities better linked to Clinical Immunology. The CIS Council is looking forward to these exciting changes and will be calling on our members for assistance and insight as we move forward with implementation. If you have any questions or suggestions about any of the above initiatives, please don't hesitate to contact the National Office at 414.224.8095 or [email protected]. And don't forget to qsave the datesq May 20-23, 2010 for the inaugural CIS meeting in Philadelphia. Sincerely, Carl June, MD President, CIS Steve Holland, MD President-Elect